Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies

作者
Nicola J. Adderley,Krishnarajah Nirantharakumar,Tom Marshall
出处
期刊: 卷期号:361: k1717-k1717 被引量:52
标识
DOI:10.1136/bmj.k1717
摘要

OBJECTIVES: To determine rates of stroke or transient ischaemic attack (TIA) and all cause mortality in patients with a diagnosis of "resolved" atrial fibrillation compared to patients with unresolved atrial fibrillation and without atrial fibrillation. DESIGN: Two retrospective cohort studies. SETTING: General practices contributing to The Health Improvement Network, 1 January 2000 to 15 May 2016. PARTICIPANTS: Adults aged 18 years or more with no previous stroke or TIA: 11 159 with resolved atrial fibrillation, 15 059 controls with atrial fibrillation, and 22 266 controls without atrial fibrillation. MAIN OUTCOME MEASURES: Primary outcome was incidence of stroke or TIA. Secondary outcome was all cause mortality. RESULTS: Adjusted incidence rate ratios for stroke or TIA in patients with resolved atrial fibrillation were 0.76 (95% confidence interval 0.67 to 0.85, P<0.001) versus controls with atrial fibrillation and 1.63 (1.46 to 1.83, P<0.001) versus controls without atrial fibrillation. Adjusted incidence rate ratios for mortality in patients with resolved atrial fibrillation were 0.60 (0.56 to 0.65, P<0.001) versus controls with atrial fibrillation and 1.13 (1.06 to 1.21, P<0.001) versus controls without atrial fibrillation. When patients with resolved atrial fibrillation and documented recurrent atrial fibrillation were excluded the adjusted incidence rate ratio for stroke or TIA was 1.45 (1.26 to 1.67, P<0.001) versus controls without atrial fibrillation. CONCLUSION: Patients with resolved atrial fibrillation remain at higher risk of stroke or TIA than patients without atrial fibrillation. The risk is increased even in those in whom recurrent atrial fibrillation is not documented. Guidelines should be updated to advocate continued use of anticoagulants in patients with resolved atrial fibrillation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
风吹雨打叶完成签到,获得积分20
2秒前
2秒前
Copyright应助猪猪侠采纳,获得10
5秒前
云为翳完成签到,获得积分10
5秒前
6秒前
野猪佩琪完成签到,获得积分10
9秒前
11秒前
蒸的菜完成签到,获得积分10
11秒前
风吹雨打叶关注了科研通微信公众号
11秒前
12秒前
12秒前
十四完成签到,获得积分10
13秒前
小赵完成签到,获得积分10
13秒前
14秒前
15秒前
潇洒的马里奥完成签到,获得积分10
16秒前
123发布了新的文献求助10
17秒前
Alice完成签到 ,获得积分10
17秒前
17秒前
逍遥发布了新的文献求助10
18秒前
20秒前
leavesziqi发布了新的文献求助10
21秒前
21秒前
冷静雨梅完成签到,获得积分10
23秒前
23秒前
阿边发布了新的文献求助10
24秒前
卡比兽mini完成签到 ,获得积分10
24秒前
24秒前
爱看文献的蓝桥完成签到,获得积分10
25秒前
28秒前
李李发布了新的文献求助30
28秒前
简单的老头完成签到,获得积分10
29秒前
32秒前
32秒前
32秒前
Claire完成签到,获得积分10
33秒前
34秒前
科研通AI6.3应助leavesziqi采纳,获得10
34秒前
AN发布了新的文献求助10
35秒前
笨笨云朵完成签到,获得积分10
36秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
适配Micro-LED色转换的高兼容性量子点负性光刻胶制备与工艺研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7316015
求助须知:如何正确求助?哪些是违规求助? 8932013
关于积分的说明 18934021
捐赠科研通 6975988
什么是DOI,文献DOI怎么找? 3213973
关于科研通互助平台的介绍 2381965
邀请新用户注册赠送积分活动 2192617